HolderBook

Millrace Asset Group, Inc.

Reported holdings as of Q3 2024, from 24 quarterly filings.

This filer last reported in Q3 2024; the most recent quarter on file across all filers is Q3 2026. Firms that restructure stop filing under one CIK and start under another, so a successor entity may hold these positions now under a similar name.

CIK
1604831
Reported value
$98.4M
Positions
70
Top 10 weight
25.6%
Filed
2024-11-13
Days after quarter end
44

Holdings

Download these holdings as CSV

SecurityTickerValue SharesWeightWeight change Held Change
SPDR SERIES TRUSTXBI$3.2M32,8473.30%+0.14pp2q-6.2%-$213.9K
HURON CONSULTING GROUP INCHURN$2.7M24,7522.73%+0.12pp2q-9.4%-$278.1K
SPDR SERIES TRUSTKRE$2.7M47,4642.73%-newNEW
REPAY HLDGS CORPRPAY$2.6M323,1392.68%+1.63pp6q+216.7%+$1.8M
SHIFT4 PMTS INCFOUR$2.4M27,1512.44%+0.53pp2q+1.1%+$27.3K
AVEPOINT INCAVPT$2.4M204,1422.44%+0.09pp3q-12.3%-$337.7K
SEMTECH CORPSMTC$2.4M52,4052.43%-newNEW
ZETA GLOBAL HOLDINGS CORPZETA$2.3M78,0712.37%-0.41pp9q-51.8%-$2.5M
MAGNITE INCMGNI$2.3M165,3302.33%-0.43pp3q-22.6%-$669.9K
RUSH STREET INTERACTIVE INCRSI$2.1M196,8142.17%-newNEW
OSI SYSTEMS INCOSIS$2.1M13,8792.14%-0.04pp3q-15.1%-$373.5K
ICU MED INCICUI$2.1M11,3302.10%+0.51pp2q-17.7%-$444.9K
C H ROBINSON WORLDWIDE INCHRW$2.0M18,4712.07%+0.76pp2q+20.8%+$351.3K
SENTINELONE INCS$2.0M85,0132.07%-newNEW
ATRICURE INCATRC$2.0M71,7082.04%+0.49pp3q+2.4%+$46.6K
TREX INCTREX$2.0M30,1852.04%-newNEW
FLUOR CORPFLR$2.0M41,9042.03%+0.05pp5q-10.7%-$240.8K
TANDEM DIABETES CARE INCTNDM$2.0M46,3041.99%-newNEW
LOVESAC COLOVE$2.0M68,5031.99%+1.07pp18q+63.0%+$758.8K
VSE CORPVSEC$1.9M23,3641.96%+0.04pp2q+4.3%+$79.1K
GENIUS SPORTS LIMITEDGENI$1.9M241,9341.93%-newNEW
FRANKLIN COVEY COFC$1.8M44,1361.84%+0.20pp2q-0.9%-$16.4K
AVID BIOSERVICES INCCDMO$1.8M155,7961.80%+0.53pp2q-15.1%-$314.9K
VIEMED HEALTHCARE INCVMD$1.7M231,3221.72%+0.42pp4q+13.3%+$198.6K
CONMED CORPCNMD$1.7M23,1451.69%-newNEW
CARPENTER TECHNOLOGY CORPCRS$1.7M10,4091.69%+0.26pp3q-22.4%-$480.6K
GLOBUS MED INCGMED$1.7M23,1511.68%+0.21pp4q+4.4%+$69.9K
HEALTH CATALYST INCHCAT$1.6M192,6161.59%-newNEW
NATERA INCNTRA$1.5M12,1441.57%+0.52pp4q+22.5%+$282.9K
ARLO TECHNOLOGIES INCARLO$1.5M127,1311.56%+0.44pp3q+43.5%+$467.0K
PDF SOLUTIONS INCPDFS$1.5M46,1361.49%-0.61pp3q-22.2%-$416.7K
DRIVEN BRANDS HLDGS INCDRVN$1.4M99,5211.44%-newNEW
ADAPTIVE BIOTECHNOLOGIES CORADPT$1.4M272,6811.42%-newNEW
PULMONX CORPLUNG$1.4M167,7251.41%-newNEW
INTERNATIONAL MONEY EXPRESSIMXI$1.4M74,0231.39%-newNEW
MIDDLEBY CORPMIDD$1.4M9,8311.39%-newNEW
FLOWSERVE CORPFLS$1.3M26,0241.37%+0.06pp3q-7.1%-$102.6K
SITIME CORPSITM$1.3M7,6341.33%+0.61pp20q+28.3%+$288.4K
SPORTRADAR GROUP AGSRAD$1.3M105,5091.30%-newNEW
ENOVIX CORPORATIONENVX$1.3M134,1401.27%-0.76pp13q-0.9%-$11.3K
SCOTTS MIRACLE-GRO COSMG$1.3M14,4561.27%+0.35pp4q-0.9%-$11.4K
INOGEN INCINGN$1.2M127,2851.25%+0.10pp3q-12.7%-$180.5K
OMNICELL COMOMCL$1.2M28,0431.24%-newNEW
DAVE INCDAVE$1.2M28,9121.17%-newNEW
COOPER-STANDARD HOLDINGS INCCPS$1.1M79,0201.11%-newNEW
UNIVERSAL TECHNICAL INST INCUTI$1.1M67,3151.11%+0.35pp2q+34.2%+$279.2K
SI-BONE INCSIBN$1.1M75,5421.07%-newNEW
MIMEDX GROUP INCMDXG$981.0K166,0421.00%-0.41pp6q-20.3%-$249.9K
VICTORIAS SECRET AND COVSXY$921.0K35,8500.94%-newNEW
VICOR CORPVICR$911.0K21,6290.93%flat2q-24.7%-$298.2K
ORTHOFIX MED INCOFIX$906.0K58,0270.92%-newNEW
SIGHT SCIENCES INCSGHT$874.0K138,7930.89%-newNEW
MATADOR RES COMTDR$861.0K17,4160.87%-newNEW
EXTREME NETWORKS INCEXTR$829.0K55,1240.84%-newNEW
COVENANT LOGISTICS GROUP INCCVLG$795.0K15,0440.81%+0.01pp3q-9.9%-$86.9K
KURA SUSHI USA INCKRUS$790.0K9,8100.80%-newNEW
TRANSMEDICS GROUP INCTMDX$724.0K4,6110.74%+0.05pp12q-1.2%-$8.9K
LIMBACH HLDGS INCLMB$700.0K9,2350.71%+0.19pp2q-1.1%-$7.7K
CERAGON NETWORKS LTDCRNT$681.0K248,4400.69%-0.24pp3q-35.1%-$368.0K
TRANSCAT INCTRNS$655.0K5,4210.67%-newNEW
PORTILLOS INCPTLO$622.0K46,1700.63%-0.25pp2q-50.6%-$636.0K
SEZZLE INCSEZL$592.0K3,4690.60%-1.08pp2q-82.3%-$2.8M
MERIT MED SYS INCMMSI$560.0K5,6620.57%-newNEW
OLLIES BARGAIN OUTLET HLDGSOLLI$560.0K5,7570.57%-1.43pp2q-72.6%-$1.5M
BOWMAN CONSULTING GROUP LTDBWMN$494.0K20,5330.50%-1.93pp14q-73.9%-$1.4M
MAMAS CREATIONS INCMAMA$337.0K46,1130.34%-0.57pp2q-67.1%-$686.5K
COHERENT CORPCOHR$303.0K3,4070.31%-1.00pp4q-81.7%-$1.4M
INARI MED INCNARI$286.0K6,9400.29%-1.10pp2q-76.7%-$940.4K
PROS HOLDINGS INCPRO$118.0K6,3640.12%-1.43pp8q-88.5%-$912.1K
NIAGEN BIOSCIENCE INCNAGE$93.0K25,5030.09%-newNEW

By sector

Industry comes from the SIC code on each company's own SEC filings, which is self-reported and sometimes out of date. Derivative exposure is counted with the shares. Securities the SEC assigns no industry - funds, trusts, foreign issues - are shown as not classified rather than dropped.

Business Services 18.3%Medical Devices 17.4%Software & IT Services 13.6%Semiconductors & Electronics 8.8%Retail & Consumer 4.9%Construction & Building 4.8%Telecom & Media 4.1%Healthcare Services 3.3%Transport & Logistics 2.9%Industrials 2.8%Computer Hardware 2.1%Mining & Metals 1.7%Other sectors 7.3%Not classified 8.2%
 
SectorValueShare
Business Services$18.0M18.3%
Medical Devices$17.1M17.4%
Software & IT Services$13.4M13.6%
Semiconductors & Electronics$8.7M8.8%
Retail & Consumer$4.9M4.9%
Construction & Building$4.7M4.8%
Telecom & Media$4.0M4.1%
Healthcare Services$3.2M3.3%
Transport & Logistics$2.8M2.9%
Industrials$2.7M2.8%
Computer Hardware$2.1M2.1%
Mining & Metals$1.7M1.7%
Other sectors$7.1M7.3%
Not classified$8.1M8.2%

What the disclosed book did

This is not the fund's return. A 13F shows long US equity positions only, so shorts, bonds, foreign listings, private holdings and cash are all invisible here. What this measures is the quarter's change in value of the positions this manager disclosed, had they been left untouched - the return a reader following the filing would have earned.

QuarterBookMarket DifferencePriced
Q3 2024+3.8%+5.4%-1.7%100%
Q2 2024-5.2%+4.0%-9.2%98%
Q1 2024+2.2%+10.0%-7.8%100%
Q4 2023+11.7%+11.2%+0.5%100%
Q3 2023-21.6%-3.6%-18.0%98%
Q2 2023+5.6%+8.3%-2.6%100%
Q1 2023-3.5%+7.0%-10.6%100%
Q4 2022+5.7%+7.1%-1.3%98%

Market is SPY over the same two quarter ends, priced the same way as everything else here - the median across every filer reporting it. It is a large-cap US proxy, so a manager holding small caps or biotech will beat or trail it for reasons that are not skill. Prices are quarter-end to quarter-end and say nothing about the path in between, or about trades opened and closed inside a quarter.

Quarter by quarter

QuarterValuePositions NewAddedTrimmed ExitedTop 10 Days to file
Q3 2024$98.4M702812302925.6%44
Q2 2024$103.0M712915252325.2%43
Q1 2024$99.5M652416252627.8%43
Q4 2023$101.0M672913251824.6%43
Q3 2023$81.0M562512192231.1%44
Q2 2023$95.5M531515231633.0%45
Q1 2023$85.7M541617211032.2%41
Q4 2022$88.1M481412141840.4%44
Q3 2022$79.2M52511351439.0%31
Q2 2022$106.8M611329182030.6%28
Q1 2022$137.6M681229272626.1%34
Q4 2021$171.3M822019341127.0%45
Q3 2021$160.0M73739261726.1%43
Q2 2021$191.7M831635321821.1%42
Q1 2021$185.7M852126361420.3%42
Q4 2020$143.7M782323322222.9%42
Q3 2020$123.8M772424292123.5%48
Q2 2020$97.8M743614242324.7%44
Q1 2020$66.2M612419182827.0%43
Q4 2019$91.9M651820271725.9%44
Q3 2019$85.3M641613321825.3%45
Q2 2019$96.7M66188401323.9%44
Q1 2019$118.5M611320281526.4%44
Q4 2018$109.2M63000027.9%44

Rows marked UNVERIFIED ID, PLACEHOLDER ID, TICKER AS ID or NON-CUSIP ID carry an identifier that is not a valid CUSIP. They are shown because the filer reported that money, but treat the security named with caution - hover the chip for what is wrong with it, and see the methodology.

Held counts consecutive filings in which this manager reported the position, and can reach further back than the quarters listed above: the tabs begin at Q4 2018 because earlier coverage is too sparse to describe a market, but tenure is counted over every filing we hold, some reaching to 2007. A position sold and later rebought starts again from one.

Weight change is the shift in this position's share of the whole book, in percentage points. It is the more useful column: when money flows into or out of a broad fund, almost every holding is bought or sold at once, so added and trimmed largely track flows. A weight that rose while the book shrank is a decision. Both compare with the previous quarter this filer reported, not the previous calendar quarter.